Disparities in survival by insurance status in patients with Hodgkin lymphoma

Cancer

Volumn 121, Issue 19, 2015, Pages 3515-3524

  Parikh, Rahul R ^a,b   Grossbard, Michael L ^c   Green, B Lee ^d   Harrison, Louis B ^d   Yahalom, Joachim ^e  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI HEALTH SYSTEM   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Hodgkin lymphoma; insurance; National Cancer Data Base; outcomes research; overall survival

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HEALTH DISPARITY; HEALTH INSURANCE; HODGKIN DISEASE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICALLY UNINSURED; OVERALL SURVIVAL; PATIENT ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; SURVIVAL RATE; TOTAL QUALITY MANAGEMENT; ADOLESCENT; ECONOMICS; HEALTH CARE DISPARITY; INSURANCE; MIDDLE AGED; MORTALITY; PROGNOSIS; SURVIVAL; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HEALTHCARE DISPARITIES; HODGKIN DISEASE; HUMANS; INSURANCE COVERAGE; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84941937693     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29518     Document Type: Article

References (24)

1. Siegel RL, Miller KD, Jemal A,. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65: 5-29.
2. Koroukian SM, Bakaki PM, Raghavan D,. Survival disparities by Medicaid status: an analysis of 8 cancers. Cancer. 2012; 118: 4271-4279.
3. Collins SR, Rasmussen PW, Doty MM,. Gaining ground: Americans' health insurance coverage and access to care after the Affordable Care Act's first open enrollment period. Issue Brief (Commonw Fund). 2014; 16: 1-23.
4. Flowers CR, Glover R, Lonial S, Brawley OW,. Racial differences in the incidence and outcomes for patients with hematological malignancies. Curr Probl Cancer. 2007; 31: 182-201.
5. Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY,. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol. 2008; 9: 222-231.
6. Wang M, Burau KD, Fang S, Wang H, Du XL,. Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma. Cancer. 2008; 113: 3231-3241.
7. Flowers CR, Sinha R, Vose JM,. Improving outcomes for patients with diffuse large B-cell lymphoma. CA Cancer J Clin. 2010; 60: 393-408.
8. Komrokji RS, Al Ali NH, Beg MS, et al., Outcome of diffuse large B-cell lymphoma in the United States has improved over time but racial disparities remain: review of SEER data. Clin Lymphoma Myeloma Leuk. 2011; 11: 257-260.
9. Flowers CR, Fedewa SA, Chen AY, et al., Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States. Cancer Epidemiol Biomarkers Prev. 2012; 21: 1520-1530.
10. Han X, Jemal A, Flowers CR, Sineshaw H, Nastoupil LJ, Ward E,. Insurance status is related to diffuse large B-cell lymphoma survival. Cancer. 2014; 120: 1220-1227.
11. Ward E, Halpern M, Schrag N, et al., Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin. 2008; 58: 9-31.
12. Olszewski AJ, Shrestha R, Castillo JJ,. Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base. J Clin Oncol. 2015; 33: 625-633.
13. Parikh RR, Yahalom J, Talcott JA, Grossbard ML, Harrison LB,. Early-stage Hodgkin disease: the utilization of radiation therapy and its impact on overall survival. Int J Radiat Oncol Biol Phys. 2014; 90: S5.
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-383.
15. Rutherford MJ, Dickman PW, Lambert PC,. Comparison of methods for calculating relative survival in population-based studies. Cancer Epidemiol. 2012; 36: 16-21.
16. Herbst C, Rehan FA, Skoetz N, et al., Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma. Cochrane Database Syst Rev. 2011: CD007110.
17. Abramowitz J, O'Hara B,. The financial burden of medical spending: estimates and implications for evaluating the impact of ACA reforms. Med Care Res Rev. 2015; 72: 187-199.
18. Brown ML, Riley GF, Schussler N, Etzioni R,. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care. 2002; 40: IV-104-IV-117.
19. Martin S, Ulrich C, Munsell M, Taylor S, Lange G, Bleyer A,. Delays in cancer diagnosis in underinsured young adults and older adolescents. Oncologist. 2007; 12: 816-824.
20. Yung RL, Chen K, Abel GA, et al., Cancer disparities in the context of Medicaid insurance: a comparison of survival for acute myeloid leukemia and Hodgkin's lymphoma by Medicaid enrollment. Oncologist. 2011; 16: 1082-1091.
21. Institute of Medicine. Population Health Implications of the Affordable Care Act: Workshop Summary. Washington, DC: National Academies Press; 2014.
22. Hay KA, Lee B, Goktepe O, et al., Impact of time from diagnosis to initiation of curative chemotherapy on survival of patients with diffuse large B-cell lymphoma (DLBCL). ASCO Meet Abstr. 2013; 31: 8552.
23. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB,. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002; 287: 2106-2113.
24. Hayes N, Rollins R, Weinberg A, et al., Cancer-related disparities: weathering the perfect storm through comprehensive cancer control approaches. Cancer Causes Control. 2005; 16 (suppl 1): 41-50.